🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

TFSA Investors: A Cannabis High-Dividend ETF Yielding Over 5.6%

Published 2019-08-28, 04:45 p/m
© Reuters.

Tax-Free Savings Account (TFSA) investors should buy shares in cannabis in the next year. Investors will still have plenty of opportunity to profit in 2020 from marijuana legalization, but there is no reason to wait to add these stocks to your portfolio. Marijuana legalization is here, and long-term investors are sure to profit if they purchase shares in underpriced cannabis stocks like Namaste Technologies (TSXV:N).

In fact, the best decision a TFSA investor can make today is to purchase a high-dividend exchange-traded fund (ETF) like Horizon’s Marijuana Life (TSX:HMMJ). Because most marijuana stocks do not offer dividends, Horizon’s Marijuana Life will offer higher returns than a simple investment in a popular pot stock

TFSA investors can earn a yield over 5.6% dividend by purchasing shares in Horizon’s Marijuana Life.

Benefits of ETFs Cannabis ETFs invest in a diversified basket of marijuana stocks to reduce risk and increase returns. Many investors prefer ETFs because they diversify exposure across an entire industry. These investments also reduce fees relative to traditional open-end funds.

An ETF will tend to move along with the overall direction of the industry, but with more protection than a simple stock purchase.

Cannabis ETFs have fallen in price recently along with the CannTrust scandal and price corrections in popular marijuana stocks like Canopy Growth. These price depreciations represent the perfect time to buy Horizon’s Marijuana Life.

Cannabis stocks are disappointing investors, as they correct from speculative price appreciations. None of these stocks provide the diversification of an ETF along with the high 5.6% dividend return of Horizon’s Marijuana Life.

Namaste Technologies Another option for savvy TFSA investors is to purchase shares in innovative, up-and-coming stocks with surging interest.

Namaste Technologies is by far the most innovative cannabis company in 2019. Not only is the company the first to implement online telemedicine to prescribe medical marijuana, but the company has also harnessed the power of machine learning. Namaste owns Findify, an e-commerce machine-learning application, which personalizes online experiences based on user behaviour data.

Annual growth in telemedicine typically exceeds 50%. More consumers are using online medical practitioners for routine check-ups and prescription refills. Namaste also sells vaporizers and smoking accessories through e-commerce websites in over 20 countries.

Moreover, Namaste is cheap at $0.33 per share — lowering the risk for new investors with less capital to spend. A TFSA investor can pick up 100 shares for $33 — less than a mediocre dinner for two in a restaurant.

Foolish takeaway Cannabis markets are volatile, which means that investors need to take care of which stocks to purchase. TFSA investors should look for underpriced cannabis stocks with a lower than average beta. Less-popular stocks will have avoided speculative runs in price from day traders.

Namaste Technologies is one of these stocks, and it is cheap enough to add 100 shares to a TFSA without regret.

While Namaste is a substantial long-term investment, the only downside is that it offers no dividend. Thus, investors may want to consider only a small investment, saving the majority of their available funds for high-dividend payers like Horizon’s Marijuana Life.

Fool contributor Debra Ray has no position in any of the stocks mentioned.

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2019

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.